iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

CUSIP: 46565G104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
10,000
Total 13F shares
35,010,863
Share change
-564,173
Total reported value
$383,366,744
Put/Call ratio
685%
Price per share
$10.95
Number of holders
131
Value change
-$6,188,505
Number of buys
71
Number of sells
74

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 46565G104?
CUSIP 46565G104 identifies ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q4 2023

As of 31 Dec 2023, iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,010,863 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., MPM ASSET MANAGEMENT LLC, Boxer Capital, LLC, MPM BioImpact LLC, VANGUARD GROUP INC, BVF INC/IL, MORGAN STANLEY, CITADEL ADVISORS LLC, and EcoR1 Capital, LLC. This page lists 132 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
141
Q4 2023 holders
131
Holder diff
-10
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.